Freely Filtered, a NephJC Podcast

Mar 12 2025 78 ep. 72 mins 745
Freely Filtered, a NephJC Podcast artwork

Twice monthly (aspirational) recap of the NephJC journal club. NephJC reviews the most important manuscripts which are driving nephrology forward and improving our understanding of the kidney.

  Health & Fitness  Science
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


FF 78 NephMadness, the dialysis region

Mar 12 2025 68 mins  
The FiltrateJoel TopfJordy CohenNayan AroraSpecial Guest Katie Kwon @katiekwonmd.bsky.socialMariana Murea @MarianaMureaEditing bySimon Topf and Joel TopfShow NotesNephMadness at AJKDblog.orgThe Hemodialysis RegionVote for your favorites

FF 77 Top Nephrology Stories

Feb 26 2025 72 mins  
The FiltrateJoel TopfSwapnil HiremathAC GomezSopia AmbrusoNayan AroraSpecial Guests Michelle Rheault, Director, Division of Pediatric Nephrology, Professor of MedicineTiffany Caza, Nephropathologist, Scientist and self-described Freely Filtered fan girlEditing bySimon Topf and Sophia AmbrusoShow Notes10. Healthcare Cyberattacks9. ApoE in C3 glomerulonephropathy8. Workforce woes in

FF 76 FINE ARTS

Dec 15 2024 90 mins  
NephJC covered the meta-analysis FINE HEARTS But Freely Filtered covered FINEARTS-HF the RCT of finerenone in heart failure with preserved ejection fraction

Episode 70b Do Over: Predicting Preeclampsia, the PRAECIS trial

Nov 16 2024 34 mins  
We rarely get feed back on episodes of Freely Filtered. That is until we screw up. And our episode on the PRAECIS trial did not go smoothly. One of our experts got called into the hospital and then when she came back for a one-on-one with Joel it turns out she had no experience with the test. Our bad. So we went back and re-recorded a podcast. So join us as we re-examine the newl

FF 75 NephJC Night at Kidney Week

Nov 04 2024 137 mins  
We had a great NephJC get together. We recorded the whole event and packaged it into a podcast. Musical entertainment Tim Yau (@Maximal_Change) Too Sweet by Hozier Fairy Tale of New York by written Jem Finer and Shane MacGowan. Hear it performed by the Pogues. Interview of Tom Mueller Tom Mueller author of How to Make a Killing Jade Teakall @jmteakell Graham Abra @GrahamAbra

Episode 74: Amino Acids for AKI

Oct 18 2024 92 mins  
The Filtrate:Jennie LinJoel TopfJosh WaitzmanSwapnil HiremathWith Special GuestsPedro TeixeiraJay KoynerEditor Sophia AmbrusoShow NotesThe article: A Randomized Trial of Intravenous Amino Acids for Kidney ProtectionNephJC SummaryKDIGO Clinical Practice Guideline for Acute Kidney Injury (PDF)Steve Coca study Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful

Episode 73: The KDIGO CKD 2024 Guideline Draft

Aug 01 2024 92 mins  
The draft order:Sophia AmbrusoNayan AroraSwapnil HiremathAC GomezJoel TopfEditor Nayan AroraShow NotesPrevious drafts:2021 KDIGO Hypertension —Joel, Sophia, Swap, Nayan, Josh2021 ASN Kidney Week Draft—Joel, Sophia, Swap, Nayan, Jennie2022 The ISPD Peritonitis Guideline— Joel, Sophia, Swap, Nayan2022 ASN Kidney Week Draft—Joel, Sophia, Swap, Nayan2023 ASN Kidney Week Draft�

Episode 72: Nefecon for IgAN, The NefIgArd part B trial

Jun 15 2024 92 mins  
Nefecon, coated budesonide, is the first drug labelled for IgA nephropathy and the approval path, 9-month reduction in proteinuria followed by 2 year GFR data set the stage for the GN renaissance we are currently living through.

Episode 71: The Spice must FLOW!

Jun 01 2024 83 mins  
On May 24th, at the ERA meeting in Stockholm Sweden (this will not be the last GLP1ra talk at Stockholm), Vlado Perkovic presented the previously spoiled results of FLOW. In addition to simultaneous publication in the NEJM, it made the front page in newspapers around the world. As one headline writer said, “Is there anything Ozempic can’t do?”

Episode 70: Predicting Preeclampsia, the PRAECIS trial

May 26 2024 76 mins  
Nothing terrifies nephrologists, quite like the consult from labor and delivery. And one of the most vexing questions is, “Is this preeclampsia or proteinuric CKD or a lupus flare?” Perhaps a newly approved blood test will be able to shed light on this clinical conundrum. The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) has appeared pre